Skip to content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
Get the latest shareable resources on coping with COVID-19 from NIMH: https://www.nimh.nih.gov/covid19

Director’s Messages about Depression

Coping With Coronavirus: Managing Stress, Fear, and Anxiety

By Joshua Gordon on

Each person responds to stress in different ways. In this Director’s message, Dr. Gordon talks about managing fear, anxiety, and stress related to the coronavirus pandemic.

Read More

Suicide Deaths Are a Major Component of the Opioid Crisis that Must Be Addressed

By Joshua Gordon , Nora Volkow on

September is National Suicide Prevention Awareness Month. In observance, Dr. Gordon has partnered with Dr. Volkow, Director of the National Institute on Drug Abuse (NIDA), to highlight a dimension of the opioid crisis that receives too little attention—the links between opioid use, opioid use disorder, and suicide.

Read More

New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine

By Joshua Gordon on

In his latest message, Dr. Gordon discusses the role of NIMH and other researchers in the development of esketamine, an FDA-approved, rapid-acting medication that targets treatment-resistant depression.

Read More

I’m Optimistic about Depression

By Joshua Gordon on

In this Director’s Message, Dr. Gordon discusses research-based advances in the understanding and treatment of depression.

Read More

A Bench-to-Bedside Story: The Development of a Treatment for Postpartum Depression

By Joshua Gordon on

In this message, Dr. Gordon discusses the role of NIMH and others in the bench-to-bedside story of brexanolone, which has just been approved by the FDA as the first treatment specifically for postpartum depression. 

Read More

Translational Research: From Research Findings to Transformative Treatments

By Joshua Gordon on

The American College of Neuropsychopharmacology (ACNP) focuses on research which translates basic neuroscience findings into novel treatments. In this Director’s Message, Dr. Gordon discusses some of the exciting work presented at this year’s ACNP meeting.

Read More

Moving Stress Research Forward

By Joshua Gordon on

Research tells us that severe stress can cause all kinds of adverse health outcomes, including an increased risk for mental illnesses. Dr. Gordon discusses how NIMH is trying to move the field of stress research forward, toward the translation of basic findings into clinical advances.

Read More